AAAAAA

   
Results: 1-15 |
Results: 15
Mortality and smoking in Hong Kong: case-control study of all adult deathsin 1998
Authors: Lam, TH Ho, SY Hedley, AJ Mak, KH Peto, R
Citation: Th. Lam et al., Mortality and smoking in Hong Kong: case-control study of all adult deathsin 1998, BR MED J, 323(7309), 2001, pp. 361-362
Wear debris from total hip arthroplasty presenting as an intrapelvic mass
Authors: Mak, KH Wong, TK Poddar, NC
Citation: Kh. Mak et al., Wear debris from total hip arthroplasty presenting as an intrapelvic mass, J ARTHROPLA, 16(5), 2001, pp. 674-676
Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients >= 75 with those < 75 years of age (The ROSETTA Registry)
Authors: Abenhaim, HA Eisenberg, MJ Schechter, D Lefkovits, J Goudreau, E Deligonul, U Mak, KH Duerr, R Del Core, M Huynh, T Smilovitch, M Sedlis, S Brown, DL Brieger, D
Citation: Ha. Abenhaim et al., Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients >= 75 with those < 75 years of age (The ROSETTA Registry), AM J CARD, 87(12), 2001, pp. 1392-1395
Coronary stenting in diabetic patients: Results from the ROSETTA registry
Authors: Huynh, T Eisenberg, M Deligonul, U Tsang, J Okrainec, K Schechter, D Lefkovits, J Mak, KH Brown, DL Brieger, D
Citation: T. Huynh et al., Coronary stenting in diabetic patients: Results from the ROSETTA registry, AM HEART J, 142(6), 2001, pp. 960-964
Use of routine functional resting after percutaneous transluminal coronaryangioplasty: Results from the ROSETTA Registry
Authors: Eisenberg, MJ Schechter, D Lefkovits, J Goudreau, E Deligonul, U Mak, KH Del Core, M Duerr, R Garzon, PM Huynh, T Smilovitch, M Sedlis, S Brown, DL Brieger, D Pilote, L
Citation: Mj. Eisenberg et al., Use of routine functional resting after percutaneous transluminal coronaryangioplasty: Results from the ROSETTA Registry, AM HEART J, 141(5), 2001, pp. 837-846
Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients
Authors: Mak, KH Effron, MB Moliterno, DJ
Citation: Kh. Mak et al., Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients, DRUG AGING, 16(3), 2000, pp. 179-187
Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
Authors: Mak, KH Topol, EJ
Citation: Kh. Mak et Ej. Topol, Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus, J AM COL C, 35(3), 2000, pp. 563-568
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
Authors: Bridges, CB Katz, JM Seto, WH Chan, PKS Tsang, D Ho, W Mak, KH Lim, W Tam, JS Clarke, M Williams, SG Mounts, AW Bresee, JS Conn, LA Rowe, T Hu-Primmer, J Abernathy, RA Lu, XH Cox, NJ Fukuda, K
Citation: Cb. Bridges et al., Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong, J INFEC DIS, 181(1), 2000, pp. 344-348
Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era
Authors: Brieger, DB Mak, KH Miller, DP Califf, RM Topol, EJ
Citation: Db. Brieger et al., Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era, AM HEART J, 140(1), 2000, pp. 29-33
Cost-efficacy modeling of functional testing with perfusion imaging to detect asymptomatic restenosis following percutaneous transluminal coronary angioplasty
Authors: Mak, KH Eisenberg, MJ Shaw, J
Citation: Kh. Mak et al., Cost-efficacy modeling of functional testing with perfusion imaging to detect asymptomatic restenosis following percutaneous transluminal coronary angioplasty, CATHET C IN, 48(4), 1999, pp. 352-356
Ofloxacin-resistant Vibrio cholerae O139 in Hong Kong
Authors: Kam, KM Luey, KY Cheung, TL Ho, KY Mak, KH Saw, PTA
Citation: Km. Kam et al., Ofloxacin-resistant Vibrio cholerae O139 in Hong Kong, EM INFECT D, 5(4), 1999, pp. 595-597
Update: Influenza activity - United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine (Reprinted from MMWR, vol 48, pg 374, 1999)
Authors: Hay, A Gust, I Hampson, A Nerome, K Lim, W Chan, M Saw, TA Mak, KH Canas, L Guo, Y
Citation: A. Hay et al., Update: Influenza activity - United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine (Reprinted from MMWR, vol 48, pg 374, 1999), J AM MED A, 281(23), 1999, pp. 2178-2180
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
Authors: Katz, JM Lim, W Bridges, CB Rowe, T Hu-Primmer, J Lu, XH Abernathy, RA Clarke, M Conn, L Kwong, H Lee, M Au, G Ho, YY Mak, KH Cox, NJ Fukuda, K
Citation: Jm. Katz et al., Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts, J INFEC DIS, 180(6), 1999, pp. 1763-1770
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997
Authors: Mounts, AW Kwong, H Izurieta, HS Ho, YY Au, TK Lee, M Bridges, CB Williams, SW Mak, KH Katz, JM Thompson, WW Cox, NJ Fukuda, K
Citation: Aw. Mounts et al., Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997, J INFEC DIS, 180(2), 1999, pp. 505-508
In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blockingplatelet function in plasma of patients with heparin-induced thrombocytopenia
Authors: Mak, KH Kottke-Marchant, K Brooks, LM Topol, EJ
Citation: Kh. Mak et al., In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blockingplatelet function in plasma of patients with heparin-induced thrombocytopenia, THROMB HAEM, 80(6), 1998, pp. 989-993
Risultati: 1-15 |